Inventor · disambiguated record
Daniel Cohen
Also filed as: COHEN DANIEL · COHEN DANIEL T · COHEN DANIEL TZVI
12 granted patents·4 pending applications·96 citations·filing 2000–2024
91Inventor score
Files withBRISTOL MYERS SQUIBB CO11ABBVIE INC2LYTICA THERAPEUTICS INC1MASSACHUSETTS INST TECHNOLOGY1MOLECULAR ENGINES LAB A FRENCH1
Top patents by PatentIndex Score
16 records- 0197US9434778B2Modified FGF-21 polypeptides comprising an internal deletion and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 6, 2016·31 cites·20 claims
- 0295US10406251B2PD-L1 binding polypeptides for imagingBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 10, 2019·15 cites·35 claims
- 0394US10189883B2Therapeutic uses of modified FGF-21 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 29, 2019·12 cites·20 claims
- 0494US9631004B2Modified FGF-21 polypeptides comprising an internal deletion and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 25, 2017·12 cites·17 claims
- 0591US11173219B2PD-L1 binding polypeptides for imagingBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 16, 2021·4 cites·21 claims
- 0690US10377806B2Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 13, 2019·6 cites·30 claims
- 0789US11344639B2PET imaging with PD-L1 binding polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 31, 2022·4 cites·13 claims
- 0888US11248031B2Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 15, 2022·4 cites·22 claims
- 0980US12247058B2Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 11, 2025·0 cites·21 claims
- 1074US12194110B2PD-L1 binding polypeptides for imagingBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 14, 2025·0 cites·15 claims
- 1171US2025084099A1Thiazolo[5,4-b]pyridine malt-1 inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 1267US2025000993A1Anti-human cd33 bet degrader antibody-drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 1366US2022347324A1Pet imaging with pd-l1 binding polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1462US6503502B1Nucleotide sequences, proteins, drugs and diagnostic agents of use in treating cancerMOLECULAR ENGINES LAB A FRENCH·Filed 2000·Granted Jan 7, 2003·8 cites·9 claims
- 1556US2024391965A1Stapled antimicrobial peptides (stamps) and uses thereofLYTICA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1644US10117948B2Selective arylation of dichalcogenides in biomoleculesMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Nov 6, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →